Chikungunya virus: Difference between revisions

From IDWiki
m (Aidan moved page RNA to Chikungunya virus without leaving a redirect)
Β 
(8 intermediate revisions by the same user not shown)
Line 1: Line 1:
==Background==
= Chikungunya =
===Microbiology===


*Member of the ''Alphavirus'' genus within the ''Togaviridae'' family
== Definition ==
**Closely related to [[o’nyong-nyong virus]]
*Four genotypes: East-Central-South African, West African, Indian Ocean, and Asian


===Epidemiology===
* Infection with the Chikungunya virus


*The primary vectors are ''[[Aedes aegypti]]'' and ''[[Aedes albopictus]]'' mosquitoes
== Presentation ==
*Endemic in most of Africa, Southeast Asia, the Philippines, and South and Central America
**There has been autochthonous transmission in Italy and Frace


==Clinical Manifestations==
* History
** Fever
** Rash
** Arthralgias


*Incubation period of [[Usual incubation period::1 to 12 days]]
== Management ==
*[[Causes::Fever]], [[Causes::rash]], and [[Causes::arthralgias]]
**Fever may be "saddleback", with remittance at 4 to 8 days followed by recrudescence for 2 weeks
**Arthritis is typically a symmetrical polyarticular arthritis that involves small joints and knees
***Resolves over months to a year (sometimes longer), but arthralgias (Β± arthritis) can persist for years
**Rash is macular or maculopapular, and more often central but can involve palms and soles
*Other common symptoms include headache, fatigue, nausea, vomiting, and conjunctivitis
*Bloodwork shows leukopenia, thrombocytopenia, hypocalcemia, and mild to moderate transaminase elevation
*Children are more likely to develop neurological symptoms (status epilepticus, complex seizures, and encephalitis) and dermatologic symptoms (bullous rash)


==Differential Diagnosis==
* High-dose NSAIDs
{| class="wikitable"
* May need aggressive rheumatology medications for arthritis
!Feature
* Supportive treatment
![[Dengue]]
![[Zika]]
!Chikungunya
|-
|Asymptomatic
|40-80%
|35-85%
|3-28%
|-
|Fever
| +++
| ++
| +++
|-
|Rash
| +
| +++
| ++
|-
|Conjunctivitis
|–
| ++
| +
|-
|Arthralgia
| +
| ++
| +++
|-
|Myalgia
| ++
| +
| +
|-
|Headache
| ++
| +
| ++
|-
|Hemorrhage
| ++
|–
|–
|-
|Shock
| +
|–
|–
|-
|Thrombocytopenia
| +++
| +
|–
|-
|Leukopenia
| ++
|–
| ++
|}
==Management==


*High-dose [[NSAID|NSAIDs]]
== Prognosis ==
*May need aggressive rheumatologic medications for arthritis
*Supportive treatment


==Prognosis==
* 12% risk of chronic arthralgias up to 3 years post-infection

* Neonates and elderly at highest risk for neurological sequelae
*12% risk of chronic arthralgias up to 3 years post-infection
*Neonates and elderly at highest risk for neurological sequelae

[[Category:Togaviridae]]

Latest revision as of 18:13, 22 August 2020

Background

Microbiology

  • Member of the Alphavirus genus within the Togaviridae family
  • Four genotypes: East-Central-South African, West African, Indian Ocean, and Asian

Epidemiology

  • The primary vectors are Aedes aegypti and Aedes albopictus mosquitoes
  • Endemic in most of Africa, Southeast Asia, the Philippines, and South and Central America
    • There has been autochthonous transmission in Italy and Frace

Clinical Manifestations

  • Incubation period of 1 to 12 days
  • Fever, rash, and arthralgias
    • Fever may be "saddleback", with remittance at 4 to 8 days followed by recrudescence for 2 weeks
    • Arthritis is typically a symmetrical polyarticular arthritis that involves small joints and knees
      • Resolves over months to a year (sometimes longer), but arthralgias (Β± arthritis) can persist for years
    • Rash is macular or maculopapular, and more often central but can involve palms and soles
  • Other common symptoms include headache, fatigue, nausea, vomiting, and conjunctivitis
  • Bloodwork shows leukopenia, thrombocytopenia, hypocalcemia, and mild to moderate transaminase elevation
  • Children are more likely to develop neurological symptoms (status epilepticus, complex seizures, and encephalitis) and dermatologic symptoms (bullous rash)

Differential Diagnosis

Feature Dengue Zika Chikungunya
Asymptomatic 40-80% 35-85% 3-28%
Fever +++ ++ +++
Rash + +++ ++
Conjunctivitis – ++ +
Arthralgia + ++ +++
Myalgia ++ + +
Headache ++ + ++
Hemorrhage ++ – –
Shock + – –
Thrombocytopenia +++ + –
Leukopenia ++ – ++

Management

  • High-dose NSAIDs
  • May need aggressive rheumatologic medications for arthritis
  • Supportive treatment

Prognosis

  • 12% risk of chronic arthralgias up to 3 years post-infection
  • Neonates and elderly at highest risk for neurological sequelae